Standout Papers

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration 2012 2026 2016 2021 1.8k
  1. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration (2012)
    Jeffrey S. Heier, David M. Brown et al. Ophthalmology
  2. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial (2012)
    Alasdair Coles, Cary Twyman et al. The Lancet

Immediate Impact

3 by Nobel laureates 27 from Science/Nature 81 standout
Sub-graph 1 of 20

Citing Papers

Age-Related Macular Degeneration
2024 Standout
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout

Works of Rupert Sandbrink being referenced

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
2012 Standout

Author Peers

Author Last Decade Papers Cites
Rupert Sandbrink 3659 1534 1319 3392 2759 84 8.9k
Ari Green 2673 1420 819 1438 586 111 6.2k
Sven Schippling 2967 714 1018 1369 590 115 5.6k
Orhan Aktaş 4592 2547 1458 1166 560 208 10.1k
Joep Killestein 3937 1159 1058 350 664 250 6.7k
Sverre Mørk 4249 2364 998 255 849 83 9.1k
Jaume Sastre‐Garriga 5150 780 1671 318 984 170 6.5k
Reinier O. Schlingemann 397 4159 505 7193 5248 183 12.4k
Hidenobu Tanihara 811 4733 154 5908 2844 271 10.2k
Lars Bø 6192 1768 1407 171 1167 83 9.0k
Neil Scolding 2345 2103 889 268 362 216 7.8k

All Works

Loading papers...

Rankless by CCL
2026